Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SciSparc (SPRC US)
Watchlist
83
Analysis
Health Care
•
Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Cross Asset Strategy
•
30 Aug 2022 10:38
•
Broker
Market Outlook
The SET Index is expected to move sideways up, with the resistance at 1,639/1,642 points and the support at 1,613 points (25/200-day EMA) /1,605...
Krungthai XSpring
Follow
90 Views
Share
bullish
•
Bangchak Corporation
•
23 Jul 2026 16:27
•
Broker
KTX Tactical Picks - July 23, 2026 (Eng.)
The KTX Tactical Picks portfolio is constructed by KTX, with investments limited to securities covered by at least four analysts. We have raised...
Krungthai XSpring
Follow
94 Views
Share
bullish
•
Valero Energy
•
25 Mar 2026 07:38
•
Broker
Energy (Refinery): An Explosion Occurred At A Valero Refinery (400kbd Capacity) In Texas
The Valero refinery is a large, complex facility located on the US Gulf Coast and is a net diesel exporter to Europe and Latin America.
Krungthai XSpring
Follow
142 Views
Share
bullish
•
Advanced Info Service
•
18 Aug 2025 10:01
•
Broker
Poised For A Rebound On The Back Of Thailand's Better Economic Prospects And The Outcome Of US-Ukraine Talks
The SET Index today is expected to rebound within a limited range, with the resistance at 1,270/1,280 points and the support at 1,252/1,239 points...
Krungthai XSpring
Follow
89 Views
Share
bearish
•
Major Cineplex Group
•
15 Aug 2025 10:06
•
Broker
Today's Dominant Ideas
The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points. Overall...
Krungthai XSpring
Follow
90 Views
Share
First
Previous
8
9
10
11
12
13
14
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x